KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Long-Term Investments (2017 - 2025)

Novartis Ag (NVS) has disclosed Long-Term Investments for 9 consecutive years, with $98.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments fell 17.65% to $98.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $98.0 million through Dec 2025, down 17.65% year-over-year, with the annual reading at $98.0 million for FY2025, 17.65% down from the prior year.
  • Long-Term Investments hit $98.0 million in Q4 2025 for Novartis Ag, down from $119.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $205.0 million in Q4 2021 to a low of $98.0 million in Q4 2025.
  • Historically, Long-Term Investments has averaged $154.0 million across 5 years, with a median of $143.0 million in 2022.
  • Biggest five-year swings in Long-Term Investments: crashed 92.93% in 2021 and later soared 43.36% in 2023.
  • Year by year, Long-Term Investments stood at $205.0 million in 2021, then tumbled by 30.24% to $143.0 million in 2022, then skyrocketed by 43.36% to $205.0 million in 2023, then plummeted by 41.95% to $119.0 million in 2024, then dropped by 17.65% to $98.0 million in 2025.
  • Business Quant data shows Long-Term Investments for NVS at $98.0 million in Q4 2025, $119.0 million in Q4 2024, and $205.0 million in Q4 2023.